Sibylla Biotech is a biotechnology company specializing in development of small molecule folding interfering degraders (FIDs). It uses the pharmacological protein inactivation by folding intermediate targeting (PPI-FIT) technology. The research areas of the company include oncology, antibiotic resistance, and therapeutics.